Oral drug absorption studies: The best model for man is man!

Drug Discovery Today

Volumn 6, Issue 3, 2001, Pages 127-130

  Davis, S S ^a   Wilding, I R ^a  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST; DOG; DRUG ABSORPTION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG INDUSTRY; HUMAN; INTESTINE ABSORPTION; MARKETING; MODEL; NONHUMAN; SHORT SURVEY; TECHNOLOGY;

EID: 0035253040     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01653-6     Document Type: Short Survey

References (6)

1. Evolution of the Biopharmaceutics Classification System (BCS) to Oral modified release (MR) formulations; what do we need to consider?
2. Site specific delivery in the gastrointestinal tract
3. 15N-labelled drug to healthy volunteers
4. Gastrointestinal transit of a putative bioadhesive matrix tablet: comparison of canine and human data
5. Development and validation of a pig model for colon-specific drug delivery
6. Development of a new engineering-based capsule for human drug absorption studies